TrialBMJ open2015

Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: secondary analysis of a 12-country randomised placebo-controlled trial using randomisation-based efficacy estimators.

David Gillespie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.